Clinical Trials
3 trialsNCT00525057 2021-01-22
Dalteparin in Preventing DVT in Participants With Cancer
M.D. Anderson Cancer Center
Phase NA Completed
NCT04364724 2020-04-28
CTFEA Myeloma Study
Tel-Aviv Sourasky Medical Center
Unknown
NCT01447914 2019-08-28
Tivantinib in Treating Patients With Relapsed, or Relapsed and Refractory Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Completed